About ApoVax

About company

ApoVax, Inc., a biotechnology company, develops immunotherapies for regulating the immune system to fight against diseases. Its products include ApoVax104, a recombinant protein vaccine that combines with antigens, tumors, and infectious disease markers and stimulates an immune response to create a disease-specific vaccine or therapeutic; and ProtEx, a technology that enables recombinant immunoregulatory proteins to be placed on the surface of cells, tissues, organs, and synthetic surfaces to modulate the immune system. The company’s products also include ApoVax104-HPV, a therapeutic vaccine for cervical cancer and human papillomavirus infection in women. In addition, its research programs c...